Pharmaceutical

Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023

GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.

Mar 29, 2025 - 06:00
Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023
GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.
Read the original article

Tags:

Previous Article

Ionis and Sobi agree on olezarsen commercialisation

Next Article

Oral Semaglutide Significantly Decreases Incidence of Heart Attacks and Strokes ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval

ILution travoprost by Glaukos for Open-Angle Glaucoma: ...

Jun 20, 2024

The unmet need in T2-low asthma: A critical gap in treatment

The unmet need in T2-low asthma: A critical gap in trea...

Jan 4, 2025

Opinion: Stanford President Marc Tessier-Lavigne and the new standards of scientific conduct

Opinion: Stanford President Marc Tessier-Lavigne and th...

Jul 22, 2023